A detailed history of Core Cap Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Core Cap Advisors, LLC holds 7,575 shares of NVO stock, worth $631,300. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,575
Holding current value
$631,300
% of portfolio
0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$119.07 - $145.42 $901,955 - $1.1 Million
7,575 New
7,575 $901,000
Q1 2024

Aug 08, 2024

BUY
$102.11 - $135.92 $671,475 - $893,809
6,576 New
6,576 $844,000
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $107,369 - $141,690
1,047 New
1,047 $141,000
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $93,741 - $110,603
908 New
908 $101,000
Q1 2022

Apr 29, 2022

SELL
$93.1 - $112.54 $92,913 - $112,314
-998 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$95.88 - $117.08 $95,688 - $116,845
998 New
998 $112,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $188B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.